Through his consultative approach and industry expertise, he introduces the ICS foundation of order-to-cash services as well as value-added solutions. Mr. Letow serves as the strategic lead for ICS in the Cell and Gene Therapy space, and works in parallel with AmerisourceBergen sister companies to continually present our strategic offering.
Mr. Letow first joined ICS in 2013 as a Proposal Development Coordinator, responsible for responding to RFPs, lead tracking and aligning closely with internal business unit support. In 2015 he moved into a Business Development role where his responsibilities included managing all aspects of winning new business.
Mr. Letow holds a Bachelor’s Degree in Business Administration from the University of Oklahoma.